Objective measures for the progression of Parkinson's disease

被引：2
|
作者：
Snow, B [1 ]
机构：
[1] Auckland Hosp, Auckland, New Zealand
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2003年 / 74卷 / 03期
关键词：
D O I：
10.1136/jnnp.74.3.287
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [41] Targeting the Progression of Parkinson's Disease
    George, J. L.
    Mok, S.
    Moses, D.
    Wilkins, S.
    Bush, A. I.
    Cherny, R. A.
    Finkelstein, D. I.
    [J]. CURRENT NEUROPHARMACOLOGY, 2009, 7 (01) : 9 - 36
  • [42] Treatment for the progression of Parkinson's disease
    Calne, D
    Schulzer, M
    Mak, E
    Stoessl, AJ
    [J]. LANCET NEUROLOGY, 2005, 4 (04): : 206 - 206
  • [43] Lifestyle and Parkinson's disease progression
    Ascherio, Alberto
    Schwarzschild, Michael A.
    [J]. MOVEMENT DISORDERS, 2019, 34 (01) : 7 - 8
  • [44] Prevention of progression in Parkinson's disease
    Aaseth, Jan
    Dusek, Petr
    Roos, Per M.
    [J]. BIOMETALS, 2018, 31 (05) : 737 - 747
  • [45] Association of real-world wearable mobility measures with Parkinson's disease severity and disease progression
    Mirelman, A.
    Volkov, J.
    Solomon, A.
    Gazit, E.
    Nieuwboer, A.
    Del Din, S.
    Rochester, L.
    Avanzino, L.
    Pelosin, E.
    Bloem, B.
    Della Croce, U.
    Cereatti, A.
    Thaler, A.
    Shirvan, J.
    Cedarbaum, J.
    Giladi, N.
    Hausdorff, J.
    [J]. MOVEMENT DISORDERS, 2023, 38 : S786 - S786
  • [46] Prevention of progression in Parkinson’s disease
    Jan Aaseth
    Petr Dusek
    Per M. Roos
    [J]. BioMetals, 2018, 31 : 737 - 747
  • [47] Levodopa and the progression of Parkinson's disease
    Fahn, S
    Shoulson, I
    Kieburtz, K
    Rudolph, A
    Lang, A
    Olanow, CW
    Tanner, C
    Marek, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24): : 2498 - 2508
  • [48] The progression of pathology in Parkinson's disease
    Halliday, Glenda Margaret
    McCann, Heather
    [J]. YEAR IN NEUROLOGY 2, 2010, 1184 : 188 - 195
  • [49] Objective gait measures as markers for disease progression in multiple sclerosis
    Gudesblatt, Mark
    Lamberg, Eric
    McKenna, Raymond
    Zarif, Myassar
    Burke, Chris
    Gutman, Max
    Bumstead, Barbara
    Fafard, Lori
    Seidel, Carole
    Cruz, Lourdes
    Fahie, Serina
    Bohuslaw, Joan
    Riley, Susan
    Graffitti, Laura
    Muratori, Lisa
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (08) : 1021 - 1021
  • [50] Objective and subjective measures of sleep in patients with Parkinson's disease before and after dopaminergic treatment
    Kaynak, D.
    Kiziltan, G.
    Benbir, G.
    Kaynak, H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 104 - 104
12345